A detailed history of New York State Common Retirement Fund transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,228 shares of CRSP stock, worth $60,896. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,228
Previous 1,228 -0.0%
Holding current value
$60,896
Previous $84,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$38.62 - $72.18 $47,425 - $88,637
1,228 New
1,228 $77,000
Q2 2022

Aug 04, 2022

SELL
$43.23 - $73.83 $256,526 - $438,107
-5,934 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$53.19 - $79.24 $106,380 - $158,480
2,000 Added 50.84%
5,934 $372,000
Q4 2021

Feb 02, 2022

BUY
$70.09 - $111.29 $10,513 - $16,693
150 Added 3.96%
3,934 $298,000
Q2 2021

Aug 02, 2021

SELL
$100.84 - $161.89 $105,882 - $169,984
-1,050 Reduced 21.72%
3,784 $613,000
Q1 2021

May 11, 2021

SELL
$110.72 - $210.04 $333,267 - $632,220
-3,010 Reduced 38.37%
4,834 $589,000
Q4 2020

Feb 08, 2021

BUY
$79.67 - $173.23 $415,080 - $902,528
5,210 Added 197.8%
7,844 $1.2 Million
Q1 2020

May 06, 2020

SELL
$33.68 - $62.53 $101,410 - $188,277
-3,011 Reduced 53.34%
2,634 $112,000
Q4 2019

Feb 05, 2020

BUY
$36.68 - $73.13 $112,277 - $223,850
3,061 Added 118.46%
5,645 $344,000
Q3 2019

Nov 07, 2019

BUY
$40.99 - $52.56 $18,445 - $23,652
450 Added 21.09%
2,584 $106,000
Q2 2019

Aug 09, 2019

SELL
$35.45 - $48.2 $7,090 - $9,640
-200 Reduced 8.57%
2,134 $101,000
Q1 2019

May 08, 2019

SELL
$28.02 - $40.87 $4,203 - $6,130
-150 Reduced 6.04%
2,334 $83,000
Q4 2018

Feb 08, 2019

SELL
$22.73 - $42.34 $104,989 - $195,568
-4,619 Reduced 65.03%
2,484 $71,000
Q3 2018

Nov 07, 2018

SELL
$44.35 - $65.71 $110,342 - $163,486
-2,488 Reduced 25.94%
7,103 $315,000
Q2 2018

Aug 10, 2018

SELL
$42.62 - $73.59 $4,262 - $7,359
-100 Reduced 1.03%
9,591 $564,000
Q1 2018

May 10, 2018

BUY
$23.52 - $58.17 $26,036 - $64,394
1,107 Added 12.9%
9,691 $443,000
Q4 2017

Feb 13, 2018

SELL
$16.95 - $23.48 $181,229 - $251,048
-10,692 Reduced 55.47%
8,584 $202,000
Q3 2017

Nov 06, 2017

BUY
$16.75 - $20.66 $322,873 - $398,242
19,276
19,276 $344,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.87B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.